Thomas Trimarchi - 16 Aug 2024 Form 4 Insider Report for BridgeBio Pharma, Inc. (BBIO)

Role
President and COO
Signature
/s/ Brian C. Stephenson, Attorney-in-Fact
Issuer symbol
BBIO
Transactions as of
16 Aug 2024
Transactions value $
-$437,638
Form type
4
Date filed
20 Aug 2024, 18:24
Previous filing
08 Aug 2024
Next filing
19 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BBIO Common Stock Tax liability -$438K -17.9K -4.33% $24.40 396K 16 Aug 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 32,431 shares of Common Stock underlying the Reporting Person's restricted stock units.